Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, M.
Right arrow Articles by David, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, M.
Right arrow Articles by David, C. S.
NEUROLOGY 1986;36:964
© 1986 American Academy of Neurology

Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune-response gene products (Ia antigens)

Moses Rodriguez, MD, William P. Lafuse, PhD, Julian Leibowitz, MD, PhD and Chella S. David, PhD

Departments of Neurology (Dr. Rodriguez) and Immunology (Drs. Rodriguez, Lafuse, and David), Mayo Clinic and Mayo Foundation, Rochester, MN; and the Department of Pathology (Dr. Leibowitz), University of Texas Medical School at Houston, TX.

In vivo administration of monoclonal antibody reactive with major histocompatibility complex-encoded Ia molecules (I-A8) partially suppressed inflammation and demyelination in the spinal cord of SJL/J (H-28) mice persistently infected with Theiler's murine encephalomyelitis virus. Demyelination was decreased if antibody was given at the time of virus inoculation or after inflammation had been established in the spinal cord. The decrease in demyelination was independent of isolation of infectious virus from the CNS or of serum titers of immunoglobulin to purified viral antigen. Thus, Theiler's virus-induced demyelination is mediated, in part, by immune cells that carry Ia class II molecules.

Address correspondence and reprint requests to Dr. Rodriguez, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

Moses Rodriguez is the recipient of a Teacher-Investigator Award (NS-00849) from the National Institutes of Health and is a Rappaport Scholar of the Mayo Clinic and Mayo Foundation.

Accepted for publication November 13, 1985.




This article has been cited by other articles:


Home page
J. Virol.Home page
J. Myoung, Y. Y. Bahk, H. S. Kang, M. C. Dal Canto, and B. S. Kim
Anticapsid Immunity Level, Not Viral Persistence Level, Correlates with the Progression of Theiler's Virus-Induced Demyelinating Disease in Viral P1-Transgenic Mice
J. Virol., June 1, 2008; 82(11): 5606 - 5617.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Y.-H. Jin, M. Mohindru, M. H. Kang, A. C. Fuller, B. Kang, D. Gallo, and B. S. Kim
Differential Virus Replication, Cytokine Production, and Antigen-Presenting Function by Microglia from Susceptible and Resistant Mice Infected with Theiler's Virus
J. Virol., November 1, 2007; 81(21): 11690 - 11702.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. S. M. Kumar, H. V. Reddi, A. Y. Kung, M. Dal Canto, and H. L. Lipton
Virus Persistence in an Animal Model of Multiple Sclerosis Requires Virion Attachment to Sialic Acid Coreceptors
J. Virol., August 15, 2004; 78(16): 8860 - 8867.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Rodriguez, L. J. Zoecklein, C. L. Howe, K. D. Pavelko, J. D. Gamez, S. Nakane, and L. M. Papke
Gamma Interferon Is Critical for Neuronal Viral Clearance and Protection in a Susceptible Mouse Strain following Early Intracranial Theiler's Murine Encephalomyelitis Virus Infection
J. Virol., November 15, 2003; 77(22): 12252 - 12265.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. D. Pavelko, C. L. Howe, K. M. Drescher, J. D. Gamez, A. J. Johnson, T. Wei, R. M. Ransohoff, and M. Rodriguez
Interleukin-6 Protects Anterior Horn Neurons from Lethal Virus-Induced Injury
J. Neurosci., January 15, 2003; 23(2): 481 - 492.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X. Lin, M. K. Njenga, A. J. Johnson, K. D. Pavelko, C. S. David, L. R. Pease, and M. Rodriguez
Transgenic Expression of Theiler's Murine Encephalomyelitis Virus Genes in H-2b Mice Inhibits Resistance to Virus-Induced Demyelination
J. Virol., June 27, 2002; 76(15): 7799 - 7811.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. L. Neville, M. C. Dal Canto, J. A. Bluestone, and S. D. Miller
CD28 Costimulatory Blockade Exacerbates Disease Severity and Accelerates Epitope Spreading in a Virus-Induced Autoimmune Disease
J. Virol., September 15, 2000; 74(18): 8349 - 8357.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. M. Drescher, P. D. Murray, X. Lin, J. A. Carlino, and M. Rodriguez
TGF-{beta}2 Reduces Demyelination, Virus Antigen Expression, and Macrophage Recruitment in a Viral Model of Multiple Sclerosis
J. Immunol., March 15, 2000; 164(6): 3207 - 3213.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
K. M. Drescher, S. L. Johnston, W. Hogancamp, G. H. Nabozny, C. S. David, I. J. Rimm, P. J. Wettstein, and M. Rodriguez
V{beta}8+ T cells protect from demyelinating disease in a viral model of multiple sclerosis
Int. Immunol., March 1, 2000; 12(3): 271 - 280.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Palma, R. L. Yauch, S. Lang, and B. S. Kim
Potential Role of CD4+ T Cell-Mediated Apoptosis of Activated Astrocytes in Theiler's Virus-Induced Demyelination
J. Immunol., June 1, 1999; 162(11): 6543 - 6551.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. J. McCright, I. Tsunoda, F. G. Whitby, and R. S. Fujinami
Theiler's Viruses with Mutations in Loop I of VP1 Lead to Altered Tropism and Pathogenesis
J. Virol., April 1, 1999; 73(4): 2814 - 2824.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. Inoue, C.-S. Koh, M. Yamazaki, H. Yahikozawa, M. Ichikawa, H. Yagita, and B. S. Kim
Suppressive Effect on Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease by the Administration of Anti-IL-12 Antibody
J. Immunol., November 15, 1998; 161(10): 5586 - 5593.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. D. Murray, K. D. Pavelko, J. Leibowitz, X. Lin, and M. Rodriguez
CD4+ and CD8+ T Cells Make Discrete Contributions to Demyelination and Neurologic Disease in a Viral Model of Multiple Sclerosis
J. Virol., September 1, 1998; 72(9): 7320 - 7329.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J.-F. Bureau, K. M. Drescher, L. R. Pease, T. Vikoren, M. Delcroix, L. Zoecklein, M. Brahic, and M. Rodriguez
Chromosome 14 Contains Determinants That Regulate Susceptibility to Theiler's Virus–Induced Demyelination in the Mouse
Genetics, April 1, 1998; 148(4): 1941 - 1949.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
B. S. Kim, R. L. Yauch, Y. Y. Bahk, J.-A. Kang, M. C. Dal Canto, and C. K. Hall
A Spontaneous Low-Pathogenic Variant of Theiler's Virus Contains an Amino Acid Substitution within the Predominant VP1233-250 T-Cell Epitope
J. Virol., February 1, 1998; 72(2): 1020 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
R. C. Woody, R. W. Steele, R. K. Charlton, and V. Smith
Histocompatibility Determinants in Childhood Postinfectious Encephalomyelitis
J Child Neurol, July 1, 1989; 4(3): 204 - 207.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.